Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
Fujian Maternity and Child Health Hospital
300 participants
Feb 1, 2024
OBSERVATIONAL
Conditions
Summary
The clinical diagnosis and treatment data of 300 cases of cervical neuroendocrine tumors were collected, including age, preoperative biopsy pathology results, postoperative histopathological results, TCT results, and colposcopy biopsy pathology results. At the same time, paraffin tissue specimens (remaining specimens after pathological diagnosis) from 100 cases of cervical neuroendocrine tumors from multiple centers across the country were collected to establish a cervical neuroendocrine tumor data follow-up database. Protein concentration and omics analysis were performed on the data results, to evaluate the molecular characteristics and prognosis of cervical neuroendocrine tumor proteins, and to preliminarily explore its clinical application value.
Eligibility
Inclusion Criteria2
- Patients diagnosed with cervical neuroendocrine carcinoma by histopathology
- Clinical data were complete
Exclusion Criteria4
- Patients who are not being treated in our hospital
- Patients with lack of follow-up data, unable to obtain survival information
- Patients call to refuse to participate in this project
- The quality of paraffin specimens can not meet the requirements of proteome concentration determination
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06276309